CMS and FDA Launch RAPID Coverage Pathway for Breakthrough Medical Devices

CMS and FDA announced the Regulatory Alignment for Predictable and Immediate Device (RAPID) coverage pathway to accelerate Medicare patient access to FDA-designated Class II and Class III Breakthrough Devices. The new pathway is designed to expedite coverage decisions for life-changing medical technologies.